8824 J. Am. Chem. Soc., Vol. 119, No. 38, 1997
Molander and Retsch
1.97 (m, 2H), 1.98-2.07 (m, 1H), 2.18-2.25 (m, 1H), 2.29-2.36 (m,
2H), 3.20 (dd, J ) 9.1, 7.0 Hz, 1H), 3.29 (s, 3H), 3.32 (dd, J ) 9.1,
(2.45 mmol) of 90% t-BuOOH solution was weighed out and 1.2 mL
of DMF was added. To this solution at 0 °C, 0.103 g (2.56 mmol) of
KH was slowly added. This produced a slightly foamy pink solution
which was allowed to warm to room temperature. A solution of 21a,
105 mg, 0.25 mmol, 0.2 M in DMF was slowly added via syringe.
After 3 h of stirring at room temperature, no starting material could be
detected by TLC. To this solution 0.5 g of Na2S2O3‚5H2O was slowly
added and the sides of the flask were rinsed down with hexanes. All
of the volatiles were removed in vacuo. The resulting solids were
extracted with CHCl3, concentrated, and flashed using 1:1 EtOAc/
hexanes followed by EtOAc. Concentration followed by recrystalli-
zation from CHCl3 afforded 80% (0.042 mg, 0.20 mmol) of the diol
36 as white needle-like crystals (>99% pure by GC analysis): mp 107
°C; Rf 0.50 (in EtOAc); 1H NMR (400 MHz, CDCl3) δ 0.93-1.28 (m,
5H), 1.52-1.68 (m, 6H), 1.95-2.06 (m, 2H), 2.12-2.22 (m, 2H), 2.37-
2.44 (m, 2H), 2.60 (br s, 1H), 3.58 (dd, J ) 10.7, 8.2 Hz, 1H), 3.80
(dd, J ) 10.7, 4.9 Hz, 1H), 4.04 (dt, J ) 6.8, 7.0 Hz, 1H), 4.98 (dq,
J ) 9.1, 2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 25.67, 25.95,
26.01, 32.40, 32.76, 33.07, 38.06, 53.35, 64.51, 129.32, 136.99; IR
(neat) 3388 cm-1 (br); HRMS calcd for C13H22O2 210.1620, found
210.1606; LRMS (EI) m/z (relative intensity) 210 (13), 192 (48), 161
(80), 81 (100). Anal. Calcd for C13H22O2: C, 74.24; H, 10.54.
Found: C, 74.09; H, 10.68.
1
29
5.9 Hz, 1H), 4.28-4.33 (m, J Si,H ) 195 Hz, 2H), 5.05 (dd, J ) 9.1,
2.1 Hz, 1H), 7.31-7.39 (m, 3H), 7.55-7.58 (m, 2H); 13C NMR (100
MHz, CDCl3) δ 14.94, 26.08, 26.17, 27.14, 27.60, 33.02, 33.09, 38.54,
43.48, 46.53, 58.77, 75.94, 127.60, 127.91, 129.36, 133.28, 135.22,
144.34; IR (neat) 2134.5 cm-1; HRMS calcd for C21H32OSi 328.2222,
found 328.2218; LRMS (EI) m/z (relative intensity) 137 (31), 107 (100),
91 (37).
(1E,2R*,3S*)-3-[[(tert-Butyldimethylsilyl)oxy]methyl]-1-(cyclo-
hexylmethylene)-2-[(phenylsilyl)methyl]cyclopentane (31) was pre-
pared from 10 according to the general experimental procedure.
Purification by flash chromatography using hexanes followed by
Kugelrohr distillation afforded 76% of 31: ot 90-110 °C/0.03 mmHg;
Rf 0.32 (10% CH2Cl2 in hexanes); 1H NMR (400 MHz, CDCl3) δ 0.00
(s, 6H), 0.86 (s, 9H), 0.95-1.04 (m, 2H), 1.09-1.28 (m, 5H), 1.34-
1.44 (m, 1H), 1.57-1.71 (m, 5H), 1.78-1.88 (m, 2H), 1.97-2.06 (m,
1H), 2.15-2.32 (m, 2H), 2.35-2.40 (m, 1H), 3.42 (B of ABX, J )
5.9, 6.2 Hz, 1H), 3.52 (A of ABX, J ) 5.9, 5.2 Hz, 1H), 4.26-4.33
1
29
(m, J
) 193.2 Hz, 2H), 5.03 (dd, J ) 9.2, 2.0 Hz, 1H), 7.30-
Si,H
7.38 (m, 3H), 7.54-7.56 (m, 2H); 13C NMR (100 MHz, CDCl3) δ
-5.35, 15.00, 18.37, 25.99, 26.11, 26.20, 26.95, 27.03, 33.06, 33.13,
38.55, 42.93, 48.97, 65.60, 127.53, 127.91, 129.34, 133.35, 135.25,
144.75; IR (neat) 2134.2 cm-1; HRMS calcd for C26H43OSi2: (M -
H)+ 427.2853, found 427.2823; LRMS (EI) m/z (relative intensity) 296
(22), 213 (72), 181 (44), 135 (44), 107 (53), 41 (100). Anal. Calcd
for C26H44OSi2: C, 72.83; H, 10.34. Found: C, 73.00; H, 10.41.
(1R*,2R*,2′R*/S*,3E)-3-[2′-[(tert-Butyldimethylsilyl)oxy]propyl-
ene]-2-[(phenylsilyl)methyl]-1-[(triisopropylsilyl)oxy]cyclopentane
(33) was prepared from 32 according to the general experimental
procedure. Purification by flash chromatography using 10% CH2Cl2
in hexanes followed by solvent removal at 0.04 mmHg afforded 83%
(0.057 g, 0.092 mmol) of the title compound as a 1.6:1 mixture of
diastereomers: Rf 0.30 (10% CH2Cl2 in hexanes); 1H NMR (400 MHz,
CDCl3) δ 0.06 (d, J ) 4.3 Hz, 3.6H), 0.08 (d, J ) 4.8 Hz, 2.4H),
0.69-0.89 (m with 2 overlapping singlets at 0.85 and 0.89, 11H), 1.01-
1.23 (m with 2 overlapping doublets at 1.10, J ) 6.4 Hz and 1.23, J )
6.3 Hz, 4H), 1.34-1.55 (m, 1H), 1.99-2.16 (m, 1H), 2.24-2.47 (m,
2H), 3.63-3.65 (m, 0.6H), 3.69-3.72 (m, 0.4H), 4.05-4.10 (m, 0.8H),
4.11-4.19 (m, 1.2H), 4.34-4.43 (m, 1H), 5.24 (br d, J ) 8.4 Hz, 0.4H)
and 5.29 (br d, J ) 8.3 Hz, 0.6H), 7.18-7.31 (m, 12H), 7.34-7.54
(m, 8H); 13C NMR (100 MHz, CDCl3) (major diasteromer) δ -4.73,
-4.43, 14.62, 18.27, 24.37, 25.63, 25.91, 30.12, 48.59, 67.39, 81.12,
86.66, 126.88, 127.57, 127.63, 127.92, 128.98, 129.37, 132.76, 135.14,
143.84, 145.20; (minor diastereomer) -4.73, -4.24, 14.92, 18.29,
24.40, 25.32, 25.99, 30.44, 48.90, 67.42, 81.17, 86.83, 126.86, 127.63,
127.72, 127.91, 128.78, 128.98, 132.69, 135.10, 143.55, 145.18; IR
(neat) 2138.0 cm-1; LRMS (EI) m/z (relative intensity) 375 (11), 243
(100), 165 (64), 105 (10), 73 (28). Anal. Calcd for C40H50O2Si2: C,
77.69; H, 8.14. Found: C, 77.49; H, 7.95.
(1E)-6-[(tert-Butyldimethylsilyl)oxy]-1-cyclohexyl-2-(phenylsilyl)-
1,7-octadiene (38). The reaction of 37 was carried out according to
the general experimental procedure except the reaction was stirred for
21 h. Purification by flash chromatography using 3% Et2O in hexanes
followed by Kugelrohr distillation afforded 93% of the title com-
pound: ot 95-110 °C/0.01 mmHg; Rf 0.57 (3% Et2O in hexanes); 1H
NMR (400 MHz, CDCl3) δ 0.02 (s, 3H), 0.03 (s, 3H), 0.89 (s, 9H),
1.05-1.50 (m, 9H), 1.60-1.73 (m, 5H), 2.18 (br t, J ) 6.5 Hz, 2H),
1
29
2.36-2.44 (m, 1H), 4.01 (br dt, J ) 5.9, 5.9 Hz, 1H), 4.52 (s, J
Si,H
) 195 Hz, 2H), 4.99 (dd, J ) 10.4, 1.2 Hz, 1H), 5.10 (dd, J ) 17.2,
1.4 Hz, 1H), 5.85 (ddd, J ) 17.0, 10.4, 6.0 Hz, 1H), 5.85 (br d, J )
9.2 Hz, 1H), 7.32-7.40 (m, 3H), 7.55-7.57 (m, 2H); 13C NMR (100
MHz, CDCl3) δ -4.83, -4.39, 18.22, 25.64, 25.76, 25.83, 25.88, 25.92,
26.00, 30.48, 32.83, 37.70, 38.02, 73.72, 113.44, 127.96, 129.44, 131.47,
132.69, 135.50, 141.69, 152.17; IR (neat) 2131.7 cm-1; HRMS calcd
for C26H43OSi2 (M - H+) 427.2853, found 427.2831; LRMS (EI) m/z
(relative intensity) 265 (32), 181 (71), 105 (20), 75 (100). Anal. Calcd
for C26H44OSi2: C, 72.83; H, 10.34. Found: C, 72.85; H, 10.59.
(1R*,2R*,3E)-1-[(tert-Butyldimethylsilyl)oxy]-3-(cyclohexylmeth-
ylene)-2-[(hexylsilyl)methyl]cyclohexane (39). The reaction of 37 was
carried out according to the general experimental procedure except
hexylsilane was used in the place of phenylsilane and the reaction was
run for 22 h. Purification by flash chromatography in hexanes afforded
1
47% of the title compound: Rf 0.50 (hexanes); H NMR (400 MHz,
CDCl3) δ -0.02 (s, 3H), 0.00 (s, 3H), 0.59-0.65 (m, 2H), 0.69-0.77
(m, 1H), 0.79-0.88 (m, 2H, with overlapping singlet at 0.79, 9H),
0.91-1.45 (m, 16H), 1.53-1.72 (m, 7H), 1.77-1.84 (m, 1H), 1.98-
2.06 (m, 3H), 2.13-2.21 (m, 1H), 3.42-3.45 (m, 1H), 3.54-3.62 (m,
(1R*,2R*,3E)-3-[5′-(2′,2′-Dimethyl-1′,3′-dioxanyl)methylene]-2-
[(phenylsilyl)methyl]-1-[(triphenylmethyl)oxy]cyclopentane (35) was
prepared from 34 according to the general experimental procedure.
Analysis of the crude reaction mixture by gas chromatography indicated
that a 35:1 diastereomeric ratio of products was formed. Purification
by flash chromatography using 10% Et2O in hexanes followed by
removal of solvents at 70 °C/0.01 mmHg to afford 88% of the desired
product as a mixture of diastereomers (>99% pure by GC analysis):
Rf 0.41 (20% Et2O in hexanes); 1H NMR (400 MHz, CDCl3) δ 0.74-
0.79 (m, 2H), 1.20-1.28 (m, 1H), 1.34-1.51 (m, 1H, with 2
overlapping singlets, 1.39, 3H and 1.44, 3H), 2.07-2.15 (m, 1H), 2.34-
2.48 (m, 2H), 2.62-2.73 (m, 1H), 3.48-3.68 (m, 4H), 3.76-3.81 (m,
1
29
J
Si,H ) 182.5 Hz, 2H), 4.9 (d, J ) 8.9 Hz, 1H); 13C NMR (100 MHz,
CDCl3) δ -4.68, -4.51, 9.56, 10.01, 14.11, 18.05, 22.56, 23.19, 25.46,
25.82, 26.11, 26.17, 31.51, 31.55, 32.57, 33.76, 33.86, 36.44, 49.84,
75.48, 130.25, 136.46; IR (neat) 2124.5 cm-1; LRMS (EI) m/z (relative
intensity) 379 (35), 189 (78), 171 (95), 105 (100), 73 (82). Anal. Calcd
for C26H52OSi2: C, 71.48; H, 12.00. Found: C, 71.76; H, 11.77.
(1R*,2R*,3E)-3-(Cyclohexylmethylene)-2-(hydroxymethyl)-1-cy-
clohexanol (41). The oxidation of 39 was carried out according to
the general procedure outlined for the oxidation of 21a with the
exception that the reaction was heated to 70 °C for 24 h. Purification
by flash chromatography in 1:1 ethyl acetate/hexanes followed by
recrystallization from hexanes afforded 13% of the expected diol as
white needle-like crystals (>98% pure by GC analysis): mp 68 °C; Rf
1
29
1H), 4.06 (t, J ) 3.4 Hz, J
) 192 Hz, 2H), 4.78 (br d, J ) 9.0
Si,H
Hz, 1H), 7.18-7.49 (m, 20H); 13C NMR (100 MHz, CDCl3) δ 14.26,
19.18, 25.91, 28.95, 30.36, 36.19, 49.03, 63.94, 63.99, 81.37, 86.75,
97.37, 117.35, 127.00, 127.72, 128.01, 129.02, 129.53, 132.62, 135.15,
145.16, 149.77; IR (neat) 2136.1 cm-1; HRMS calcd for C37H39O3Si:
(M - CH3)+ 559.2668, found 559.2680; LRMS (EI) m/z (relative
intensity) 243 (100), 165 (86), 105 (73).
1
0.26 (1:1 EtOAc/hexanes); H NMR (400 MHz, CDCl3) δ 0.96-1.37
(m, 6H), 1.50-1.76 (m, 7H), 1.84-1.90 (m, 2H), 2.14-2.24 (m, 2H),
2.30-2.38 (m, 2H), 2.62 (br d, J ) 4.8, 1H), 3.62-3.68 (m, 1H), 3.77-
3.91 (m, 2H), 4.86 (d, J ) 8.6 Hz, 1H); 13C NMR (100 MHz, CDCl3)
δ 23.78, 25.95, 27.65, 33.63, 33.78, 33.83, 36.56, 52.55, 64.15, 74.64,
130.70, 134.37; IR (neat) 3349 cm-1 (br); LRMS (EI) m/z (relative
intensity) 206 (93), 163 (65), 135 (66), 81 (100). Anal. Calcd for
C14H24O2: C, 74.95; H, 10.78. Found: C, 75.29; H, 10.89. The relative
(1R*,2R*,3E)-3-(Cyclohexylmethylene)-2-(hydroxymethyl)-1-cy-
clopentanol (36). General Procedure for the Oxidation/Deprotec-
tion of 21a. In a 50 mL Schlenk flask purged with argon 0.245 g